HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gianfranco Parati Selected Research

lacidipine

1/2019Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis.
12/2014Effect of long-term antihypertensive treatment on white-coat hypertension.
7/2012Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
6/2012Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment.
9/2009Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).
5/2007Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis.
5/2005Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gianfranco Parati Research Topics

Disease

101Hypertension (High Blood Pressure)
11/2022 - 01/2002
39Heart Failure
01/2022 - 01/2006
14Stroke (Strokes)
11/2022 - 12/2003
14Hypoxia (Hypoxemia)
01/2021 - 09/2006
11COVID-19
11/2022 - 01/2020
10Atrial Fibrillation
02/2022 - 02/2012
10Atherosclerosis
01/2022 - 05/2005
10Myocardial Infarction
01/2022 - 09/2005
9Obesity
01/2022 - 05/2010
6Cardiovascular Diseases (Cardiovascular Disease)
02/2021 - 11/2002
5Obstructive Sleep Apnea
05/2022 - 08/2002
5Insulin Resistance
02/2022 - 01/2013
5Carotid Stenosis (Carotid Artery Stenosis)
01/2022 - 08/2013
5Cardiomyopathies (Cardiomyopathy)
01/2022 - 07/2017
5Systolic Heart Failure
05/2015 - 05/2009
4Chronic Renal Insufficiency
11/2022 - 01/2020
4Syncope (Fainting)
10/2022 - 01/2020
4Sleep Apnea Syndromes (Sleep Apnea)
11/2021 - 01/2017
4Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2021 - 01/2009
4Pulmonary Hypertension
12/2020 - 09/2006
4Mitral Valve Insufficiency (Mitral Regurgitation)
09/2020 - 09/2010
4Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 01/2017
4Altitude Sickness (Mountain Sickness)
06/2016 - 09/2006
4Essential Hypertension
06/2014 - 12/2005
3Chronic Disease (Chronic Diseases)
01/2022 - 04/2012
3Dyslipidemias (Dyslipidemia)
01/2022 - 01/2009
3Neoplasms (Cancer)
10/2021 - 01/2018
3Clinical Deterioration
01/2021 - 11/2012
3Diabetes Mellitus
10/2020 - 05/2006
3Ischemia
05/2020 - 05/2015
3Acute Coronary Syndrome
01/2020 - 09/2005
3Cognitive Dysfunction
09/2014 - 08/2013
2Orthostatic Hypotension (Postural Hypotension)
10/2022 - 01/2016
2Heart Arrest (Cardiac Arrest)
01/2022 - 07/2017
2Kidney Diseases (Kidney Disease)
01/2022 - 01/2021
2Hyperuricemia
01/2022 - 01/2021
2Cardiac Sudden Death (Sudden Cardiac Arrest)
07/2021 - 01/2020
2Body Weight (Weight, Body)
01/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

40Antihypertensive Agents (Antihypertensives)IBA
07/2022 - 01/2002
20Pharmaceutical PreparationsIBA
01/2021 - 07/2003
14Uric Acid (Urate)IBA
11/2022 - 05/2006
13Oxygen (Dioxygen)IBA
01/2021 - 09/2011
8DiureticsIBA
11/2022 - 03/2002
7SodiumIBA
08/2019 - 12/2003
7lacidipineIBA
01/2019 - 05/2005
6LDL CholesterolIBA
11/2022 - 09/2014
6Brain Natriuretic Peptide (Natrecor)FDA Link
07/2016 - 05/2009
5Triglycerides (Triacylglycerol)IBA
02/2022 - 11/2002
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2009
5Carbon DioxideIBA
01/2021 - 05/2015
5Angiotensin Receptor AntagonistsIBA
01/2021 - 05/2009
5CholesterolIBA
01/2021 - 11/2002
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021 - 01/2009
5Amlodipine (Norvasc)FDA LinkGeneric
01/2020 - 10/2010
5Atenolol (Tenormin)FDA LinkGeneric
01/2019 - 05/2005
5Telmisartan (Micardis)FDA Link
01/2018 - 06/2009
4Biomarkers (Surrogate Marker)IBA
11/2022 - 07/2015
4SaltsIBA
05/2022 - 04/2003
4Clostridium perfringens epsilon-toxinIBA
10/2021 - 09/2013
4Proteins (Proteins, Gene)FDA Link
01/2019 - 04/2012
4Nifedipine (Adalat)FDA LinkGeneric
01/2018 - 03/2002
4AldosteroneIBA
04/2017 - 12/2003
4ErythropoietinFDA Link
04/2017 - 03/2011
4Simendan (Levosimendan)IBA
02/2017 - 09/2010
4CalciumIBA
03/2016 - 06/2012
3Ethanol (Ethyl Alcohol)IBA
11/2022 - 01/2020
3CreatinineIBA
01/2022 - 11/2002
3Adenosine (Adenocard)FDA LinkGeneric
01/2022 - 01/2020
3Endothelin-1 (Endothelin 1)IBA
01/2022 - 09/2006
3C-Reactive ProteinIBA
06/2021 - 01/2017
3Hemoglobins (Hemoglobin)IBA
01/2021 - 01/2015
3CytokinesIBA
01/2021 - 01/2019
3Adrenergic Agents (Adrenergic Drugs)IBA
05/2020 - 05/2012
3Valsartan (Vals)FDA Link
01/2020 - 10/2010
3Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2018 - 05/2009
3ReninIBA
04/2017 - 05/2010
3zofenoprilIBA
01/2017 - 01/2006
3Acetazolamide (Diamox)FDA LinkGeneric
01/2015 - 03/2013
3Hydrochlorothiazide (Esidrix)FDA LinkGeneric
04/2013 - 01/2006
2Dietary SodiumIBA
05/2022 - 08/2019
2LDL Lipoproteins (beta Lipoproteins)IBA
02/2022 - 07/2006
2Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2022
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 01/2019
2LipidsIBA
01/2022 - 04/2021
2Endothelins (Endothelin)IBA
01/2022 - 09/2006
2bunazosin (Andante)IBA
11/2021 - 05/2021
2Interleukin-6 (Interleukin 6)IBA
06/2021 - 09/2005
2Cadherins (E-Cadherin)IBA
01/2021 - 04/2017
2sacubitril and valsartan sodium hydrate drug combinationIBA
01/2021 - 09/2020

Therapy/Procedure

36Therapeutics
01/2022 - 01/2006
8Continuous Positive Airway Pressure
05/2022 - 08/2002
6Renal Dialysis (Hemodialysis)
01/2022 - 04/2013
6Denervation
04/2020 - 05/2012
6Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
01/2020 - 06/2009
4Cardiac Resynchronization Therapy
02/2022 - 05/2015
4Stents
12/2020 - 01/2012
4Peritoneal Dialysis
01/2020 - 04/2013
4Blood Pressure Monitors
10/2015 - 06/2007
3Artificial Respiration (Mechanical Ventilation)
01/2021 - 10/2020
2Analgesia
11/2020 - 01/2019